NASDAQ:LYEL   Lyell Immunopharma, Inc.
The most recent candle tested four fibonacci levels and closed at the .618 level. The D+ recently crossed D- on the ADX and the Force Index, long and short term turned positive.

There is bullish divergence with the OBV up while price declined from 8/9-8/23.

Looking for a short term swing trade with a 1.5XATR stop and a target of $8.84

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.